Clinical Trials Directory

Trials / Completed

CompletedNCT00805883

MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
Male
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a clinical research study designed to measure the effectiveness of focal Interstitial Laser Thermal Therapy (ILTT) at killing prostate tumours. Patients with "low risk" prostate cancer (Trans Rectal US Guided Biopsy positive) will undergo an MRI scan to try to localize the tumour. If the MRI detects the tumour they will then undergo a perineal ablative procedure (ILTT) under general anaesthetic. Seven days following ILTT they will come back to the hospital for a Radical Retoropubic Prostatectomy (RRP) procedure, which is the removal of a prostate gland through a surgical incision. After removal, the prostate will undergo further analysis to determine the exact location of cancer and evaluate the extent of cancer death caused by ILTT.

Conditions

Interventions

TypeNameDescription
PROCEDUREFocal Phothtermal AblationUnder general anasthesia and in Lithotomy position 2-4 14 Fr laser fibers will be placed into the prostate using 3D US guidance.

Timeline

Start date
2009-02-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2008-12-10
Last updated
2011-05-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00805883. Inclusion in this directory is not an endorsement.